A multi-factor model for caspase degradome prediction

BMC Genomics

Volumn 10, Issue SUPPL. 3, 2009, Pages

  Wee, Lawrence J K ^a,b   Tong, Joo Chuan ^c   Tan, Tin Wee ^a   Ranganathan, Shoba ^a,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

^c INSTITUTE FOR INFOCOMM RESEARCH   (Singapore)

^d MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; TYROSINE KINASE RECEPTOR; PROTEOME;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; COMPUTER MODEL; COMPUTER PREDICTION; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; ENZYME DEGRADATION; ENZYME SUBSTRATE; PROTEIN TARGETING; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN SECONDARY STRUCTURE;

APOPTOTIC CELL DEATH; CASPASES; CELLULAR PROCESS; CLEAVAGE SITES; CYSTEINE PROTEASE; DATA SETS; FALSE POSITIVE; HUMAN HEALTH; IN-VIVO; MULTI-FACTOR; POSITIVE PREDICTIVE VALUES; POTENTIAL SUBSTRATE; PREDICTION MODEL; RECEPTOR TYROSINE KINASE; SOLVENT EXPOSURE; SOLVENT-EXPOSED REGIONS; STRUCTURAL FACTOR; SURVIVAL AND GROWTH; TETRAPEPTIDE; TRUE POSITIVE; TWO-STEP MODEL;

AMINO ACIDS; BIOINFORMATICS; CELL DEATH; FORECASTING;

SUBSTRATES;

AMINO ACID SEQUENCE; CASPASES; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; PROTEOME;

EID: 71549169257     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-10-S3-S6     Document Type: Article

References (57)

1. López-Otín C, Overall CM. Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol 2002, 3:509-519. 10.1038/nrm858, 12094217.
2. Los M, Stroh C, Janicke RU, Engels IH, Schulze-Osthoff K. Caspases: more than just killers?. Trends Immunol 2001, 22:31-34. 10.1016/S1471-4906(00)01814-7, 11286689.
3. Algeciras-Schimnich A, Bamhart BC, Peter ME. Apoptosis-independent functions of killer caspases. Curr Opin Cell Biol 2002, 14:721-726. 10.1016/S0955-0674(02)00384-8, 12473345.
4. Launay S, Hermine O, Fontenay M, Kroemer G, Solary E, Garrido C. Vital functions for lethal caspases. Oncogene 2005, 24:5137-5148. 10.1038/sj.onc.1208524, 16079910.
5. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT, Nicholson DW. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 1997, 272:17907-11. 10.1074/jbc.272.29.17907, 9218414.
6. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999, 68:383-424. 10.1146/annurev.biochem.68.1.383, 10872455.
7. Fischer U, Janicke RU, Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 2003, 10:76-100. 10.1038/sj.cdd.4401160, 12655297.
8. Timmer JC, Salvesen GS. Caspase substrates. Cell Death Differ 2007, 14:66-72. 10.1038/sj.cdd.4402059, 17082814.
9. Ferrando-May E, Cordes V, Biller-Ckovric I, Mirkovic J, Gorlich D, Nicotera P. Caspases mediate nucleoporin cleavage, but not early redistribution of nuclear transport factors and modulation of nuclear permeability in apoptosis. Cell Death Differ 2001, 8:495-505. 10.1038/sj.cdd.4400837, 11423910.
10. Ng FW, Nguyen M, Kwan T, Branton PE, Nicholson DW, Cromlish JA, Shore GC. p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J Cell Biol 1997, 139:327-338. 10.1083/jcb.139.2.327, 2139787, 9334338.
11. Granville DJ, Carthy CM, Jiang H, Shore GC, McManus BM, Hunt DW. Rapid cytochrome c release, activation of caspases 3, 6, 7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy. FEBS Lett 1998, 437:5-10. 10.1016/S0014-5793(98)01193-4, 9804161.
12. Maatta J, Hallikas O, Welti S, Hilden P, Schroder J, Kuismanen E. Limited caspase cleavage of human BAP31. FEBS Lett 2000, 484:202-206. 10.1016/S0014-5793(00)02159-1, 11078879.
13. Mancini M, Machamer CE, Roy S, Nicholson DW, Thomberry NA, Casciola-Rosen LA, Rosen A. Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J Cell Biol 2000, 149:603-612. 10.1083/jcb.149.3.603, 2174848, 10791974.
14. Casiano CA, Ochs RL, Tan EM. Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes. Cell Death Differ 1998, 5:183-190. 10.1038/sj.cdd.4400336, 10200463.
15. Samejima K, Svingen PA, Basi GS, Kottke T, Mesner PW, Stewart L, Durrieu F, Poirier GG, Alnemri ES, Champoux JJ, Kaufmann SH, Earnshaw WC. Caspase-mediated cleavage of DNA topoisomerase I at unconventional sites during apoptosis. J Biol Chem 1999, 274:4335-4340. 10.1074/jbc.274.7.4335, 9933635.
16. Waterhouse N, Kumar S, Song Q, Strike P, Sparrow L, Dreyfuss G, Alnemri ES, Litwack G, Lavin M, Watters D. Heteronuclear ribonucleoproteins C1 and C2, components of the spliceosome, are specific targets of interleukin 1beta-converting enzyme-like proteases in apoptosis. J Biol Chem 1996, 271:29335-29341. 10.1074/jbc.271.46.29335, 8910595.
17. Chou JJ, Li H, Salvesen GS, Yuan J, Wagner G. Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 1999, 96:615-624. 10.1016/S0092-8674(00)80572-3, 10089877.
18. McDonnell JM, Fushman D, Milliman CL, Korsmeyer SJ, Cowburn D. Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 1999, 96:625-634. 10.1016/S0092-8674(00)80573-5, 10089878.
19. Otomo T, Sakahira H, Uegaki K, Nagata S, Yamazaki T. Structure of the heterodimeric complex between CAD domains of CAD and ICAD. Nat Struct Biol 2000, 7:658-662. 10.1038/77957, 10932250.
20. Woo EJ, Kim YG, Kim MS, Han WD, Shin S, Robinson H, Park SY, Oh BH. Structural mechanism for inactivation and activation of CAD/DFF40 in the apoptotic pathway. Mol Cell 2004, 14:531-539. 10.1016/S1097-2765(04)00258-8, 15149602.
21. Chai J, Wu Q, Shiozaki E, Srinivasula SM, Alnemri ES, Shi Y. Crystal structure of a procaspase-7 zymogen: Mechanisms of activation and substrate binding. Cell 2001, 107:399-407. 10.1016/S0092-8674(01)00544-X, 11701129.
22. Riedl SJ, Fuentes-Prior P, Renatus M, Kairies N, Krapp S, Huber R, Salvesen GS, Bode W. Structural basis for the activation of human procaspase-7. Proc Natl Acad Sci USA 2001, 98:14790-14795. 10.1073/pnas.221580098, 64937, 11752425.
23. Hubbard SJ, Campbell SF, Thornton JM. Molecular recognition. Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors. J Mol Biol 1991, 220:507-530. 10.1016/0022-2836(91)90027-4, 1856871.
24. Boyd SE, Pike RN, Rudy GB, Whisstock JC, Garcia de la Banda M. PoPS: a computational tool for modeling and predicting protease specificity. J Bioinform Comput Biol 2005, 3:551-85. 10.1142/S021972000500117X, 16108084.
25. Wee LJ, Tan TW, Ranganathan S. SVM-based prediction of caspase substrate cleavage sites. BMC Bioinformatics 2006, 7(Suppl 5):S14. 10.1186/1471-2105-7-S5-S14, 1764470, 17254298.
26. Wee LJ, Tan TW, Ranganathan S. CASVM: web server for SVM-based prediction of caspase substrates cleavage sites. Bioinformatics 2007, 23:3241-3. 10.1093/bioinformatics/btm334, 17599937.
27. Backes C, Kuentzer J, Lenhof HP, Comtesse N, Meese E. GraBCas: a bioinformatics tool for score-based prediction of Caspase- and Granzyme B-cleavage sites in protein sequences. Nucleic Acids Res 2005, 33(Web server issue):W208-W213. 10.1093/nar/gki433, 15980455, 1160194.
28. Hubbard SR, Miller WT. Receptor tyrosine kinases: mechanisms of activation and signaling. Curr Opin Cell Biol 2007, 19:117-123. 10.1016/j.ceb.2007.02.010, 17306972, 2536775.
29. Bae SS, Choi JH, Oh YS, Perry DK, Ryu SH, Suh PG. Proteolytic cleavage of epidermal growth factor receptor by caspases. FEBS Lett 2001, 491:16-20. 10.1016/S0014-5793(01)02167-6, 11226410.
30. He YY, Huang JL, Chignell CF. Cleavage of epidermal growth factor receptor by caspase during apoptosis is independent of its internalization. Oncogene 2006, 25:1521-1531. 10.1038/sj.onc.1209184, 16247443.
31. Tikhomirov O, Carpenter G. Caspase-dependent cleavage of ErbB-2 by geldanamycin and staurosporin. J Biol Chem 2001, 276:33675-33680. 10.1074/jbc.M101394200, 11402024.
32. Tikhomirov O, Carpenter G. Identification of ErbB-2 kinase domain motifs required for geldanamycin-induced degradation. Cancer Res 2003, 63:39-43.
33. Strohecker AM, Yehiely F, Chen F, Cryns VL. Caspase cleavage of HER-2 releases a Bad-like cell death effector. J Biol Chem 2008, 283:18269-18282. 10.1074/jbc.M802156200, 18420586, 2440621.
34. Tulasne D, Deheuninck J, Lourenco FC, Lamballe F, Ji Z, Leroy C, Puchois E, Moumen A, Maina F, Mehlen P, Fafeur V. Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage. Mol Cell Biol 2004, 24:10328-39. 10.1128/MCB.24.23.10328-10339.2004, 529022, 15542841.
35. Foveau B, Leroy C, Ancot F, Deheuninck J, Ji Z, Fafeur V, Tulasne D. Amplification of apoptosis through sequential caspase cleavage of the MET tyrosine kinase receptor. Cell Death Differ 2007, 14:752-64. 10.1038/sj.cdd.4402080, 17186028.
36. Deheuninck J, Foveau B, Goormachtigh G, Leroy C, Ji Z, Tulasne D, Fafeur V. Caspase cleavage of the MET receptor generates an HGF interfering fragment. Biochem Biophys Res Commun 2008, 367:573-577. 10.1016/j.bbrc.2007.12.177, 18187039.
37. Bordeaux MC, Forcet C, Granger L, Corset V, Bidaud C, Billaud M, Bredesen DE, Edery P, Mehlen P. The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J 2000, 19:4056-63. 10.1093/emboj/19.15.4056, 306592, 10921886.
38. Mourali J, Bénard A, Lourenço FC, Monnet C, Greenland C, Moog-Lutz C, Racaud-Sultan C, Gonzalez-Dunia D, Vigny M, Mehlen P, Delsol G, Allouche M. Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage. Mol Cell Biol 2006, 26:6209-22. 10.1128/MCB.01515-05, 1592804, 16880530.
39. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28:27-30. 10.1093/nar/28.1.27, 10592173, 102409.
40. The UniProt Consortium The Universal Protein Resource (Uniprot). Nucleic Acids Res 2008, 36:D190-D195. 10.1093/nar/gkn141, 2238893, 18045787.
41. Dix MM, Simon GM, Cravatt BF. Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell 2008, 134:679-691. 10.1016/j.cell.2008.06.038, 18724940, 2597167.
42. Tikhomirov O, Dikov M, Carpenter G. Identification of proteolytic fragments from ErbB-2 that induce apoptosis. Oncogene 2005, 24:3906-13. 10.1038/sj.onc.1208534, 15782126.
43. Hentze H, Schwoebel F, Lund S, Keel M, Ertel W, Wendel A, Jäättelä M, Leist M. In vivo and in vitro evidence for extracellular caspase activity released from apoptotic cells. Biochem Biophys Res Commun 2001, 283:1111-1117. 10.1006/bbrc.2001.4918, 11355887.
44. Cowan KN, Leung WC, Mar C, Bhattacharjee R, Zhu Y, Rabinovitch M. Caspases from apoptotic myocytes degrade extracellular matrix: a novel remodeling paradigm. FASEB J 2005, 19:1848-1850.
45. You L. Detection of cleavage sites for HIV-1 protease in native proteins. Comput Syst Bioinformatics Conf 2006, 249-56. full_text, 17369643.
46. Ahmad S, Gromiha MM, Sarai A. Analysis and prediction of DNA-binding proteins and their binding residues based on composition, sequence and structural information. Bioinformatics 2004, 20:477-486. 10.1093/bioinformatics/btg432, 14990443.
47. Jeong E, Chung IF, Miyano S. A neural network method for identification of RNA-interacting residues in protein. Genome Inform 2004, 15:105-116.
48. Wu YM, Huang CL, Kung HJ, Huang CY. Proteolytic activation of ETK/Bmx tyrosine kinase by caspases. J Biol Chem 2001, 276:17672-17678. 10.1074/jbc.M010964200, 11278797.
49. Agniswamy J, Fang B, Weber IT. Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis. FEBS J 2007, 274:4752-4765. 10.1111/j.1742-4658.2007.05994.x, 17697120.
50. Bode W, Brandstetter H, Mather T, Stubbs MT. Comparative analysis of haemostatic proteinases: structural aspects of thrombin, factor Xa, factor IXa and protein C. Thromb Haemost 1997, 78:501-511. 9198204.
51. Tözsér J, Bagossi P, Zahuczky G, Specht SI, Majerova E, Copeland TD. Effect of caspase cleavage-site phosphorylation on proteolysis. Biochem J 2003, 372:137-43. 10.1042/BJ20021901, 1223375, 12589706.
52. Wang YP, Biernat J, Pickhardt M, Mandelkow E, Mandelkow EM. Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc Natl Acad Sci U S A 2007, 104:10252-10257. 10.1073/pnas.0703676104, 17535890, 1891218.
53. Tan JA, Sun Y, Song J, Chen Y, Krontiris TG, Durrin LK. SUMO conjugation to the matrix attachment region-binding protein, special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to promyelocytic nuclear bodies where it undergoes caspase cleavage. J Biol Chem 2008, 283:18124-18134. 10.1074/jbc.M800512200, 18408014, 2440605.
54. Mahrus S, Trinidad JC, Barkan DT, Sali A, Burlingame AL, Wells JA. Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell 2008, 134:866-876. 10.1016/j.cell.2008.08.012, 18722006, 2566540.
55. Wagner M, Adamczak R, Porollo A, Meller J. Linear regression models for solvent accessibility prediction in proteins. J Comput Biol 2005, 3:355-69.
56. Adamczak R, Porollo A, Meller J. Accurate prediction of solvent accessibility using neural networks-based regression. Proteins 2004, 56:753-767. 10.1002/prot.20176, 15281128.
57. Adamczak R, Porollo A, Meller J. Combining Prediction of Secondary Structure and Solvent Accessibility in Proteins. Proteins 2005, 59:467-475. 10.1002/prot.20441, 15768403.